479 related articles for article (PubMed ID: 14716740)
41. Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia.
Kang KK; Kim JM; Yu JY; Ahn BO; Yoo M; Kim YC
Int J Urol; 2007 Oct; 14(10):946-51; discussion 951. PubMed ID: 17880297
[TBL] [Abstract][Full Text] [Related]
42. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
43. [Clinical significance of urodynamic study in benign prostatic hyperplasia].
Wei Z; Zhou Z; Zheng S
Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):54-6. PubMed ID: 7539737
[TBL] [Abstract][Full Text] [Related]
44. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
Alemu MH
Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
[TBL] [Abstract][Full Text] [Related]
45. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
Unsal A; Cimentepe E
Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
[TBL] [Abstract][Full Text] [Related]
46. A dose-dependent dual effect of oestrogen on voiding in the male mouse?
Streng TK; Talo A; Andersson KE; Santti R
BJU Int; 2005 Nov; 96(7):1126-30. PubMed ID: 16225541
[TBL] [Abstract][Full Text] [Related]
47. [New methods for the evaluation of cervico-prostatic obstruction].
Fanciullacci F; Sandri S; Politi P; Zanollo L; Spinelli M
Arch Ital Urol Nefrol Androl; 1992 Dec; 64(4):325-9. PubMed ID: 1281339
[TBL] [Abstract][Full Text] [Related]
48. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
Chancellor MB; Rivas DA; Keeley FX; Lotfi MA; Gomella LG
Br J Urol; 1994 Aug; 74(2):200-3. PubMed ID: 7522872
[TBL] [Abstract][Full Text] [Related]
49. Estradiol and high-dose dihydrotestosterone treatment causes changes in cynomolgus monkey prostate volume and histology identical to those caused by testosterone alone.
Kamischke A; Weinbauer GF; Semjonow A; Lerchl A; Richter KD; Nieschlag E
J Androl; 1999; 20(5):601-10. PubMed ID: 10520572
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
51. Comparative urodynamic patterns of bladder pressure, contractility and urine flow in man and rat during micturition.
Schmidt F; Yoshimura Y; Shin PY; Constantinou CE
APMIS Suppl; 2003; (109):39-44. PubMed ID: 12874948
[TBL] [Abstract][Full Text] [Related]
52. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
Kuo HC
Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
[TBL] [Abstract][Full Text] [Related]
53. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
[TBL] [Abstract][Full Text] [Related]
54. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
55. [Qualitative grading of detrusor contractility in benign prostatic hyperplasia patients].
Liao L; Shi B; Liang C
Zhonghua Wai Ke Za Zhi; 1997 Mar; 35(3):173-5. PubMed ID: 10374527
[TBL] [Abstract][Full Text] [Related]
56. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
Ewing LL; Berry SJ; Higginbottom EG
Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
[TBL] [Abstract][Full Text] [Related]
57. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
Hohenfellner M; Thüroff JW
Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
[TBL] [Abstract][Full Text] [Related]
58. [Value of preoperative urodynamics to the prognosis of transurethral prostate resection for benign prostatic hyperplasia].
Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
Zhonghua Nan Ke Xue; 2005 Mar; 11(3):207-9. PubMed ID: 15804115
[TBL] [Abstract][Full Text] [Related]
59. Clinical value of uroflowmentry in selected cases of bladder outlet obstruction.
Lemma BE; Taye M; Hawando T; Bakke A
Ethiop Med J; 2004 Oct; 42(4):283-7. PubMed ID: 16122120
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
